What this means
This trial plans to study how a placebo and an active skin product change the bacteria on the skin over time. It has not started yet, so no results exist.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 40–60
- Where
- Not listed
The science
- Registered title
- Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.
- Trial ID
- NCT07454525 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Skin, Skin Microbiome, Skin Microbiota, Skin Ageing
- What is tested
- Active Cream, Placebo Cream without active substance
- Sponsor
- AB Biotics, SA
- Ages
- 40 Years to 60 Years
- Dates
- First posted Mar 6, 2026 · updated Mar 6, 2026
Registry summary
The purpose of this study is to build insights to understand how the placebo and active impacts the skin microbiome in women with high skin sensitivity (SS10 > 13) and sun exposure. Microbiome samples will be taken at baseline after 2 weeks of using the placebo (base without active) as a run-in period followed by the usage of placebo for an additional 4 weeks. The participants will then start the usage of active formula for an additional 8 weeks with microbiome samples collected at the 10-week and 14-week. This will allow us to observe how the microbiome changes over time after the product usage of both placebo and active formulations relative to the pre-regimen condition. In addition, headshot photos will be taken using the Haut AI application at each time point concurrent to the microbiome sample collection to examine changes in skin appearances after the regimen.